CAPE TOWN, South Africa, July 17, 2023 (GLOBE NEWSWIRE) — via IBN — Institute of Biomedical Research Corp. (OTC PINK: MRES) (“Institute of Biomedical Research” or the “Company”), a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions, is pleased to share the following update:
M2Bio Sciences is thrilled to announce the forthcoming launch of a captivating line of Purple, White, and Green teas, sourced from the scenic tea gardens of Kenya. This meticulously crafted collection of teas not only provides an exquisite sensory experience but also delivers exceptional medicinal health benefits.
Kenya, renowned for its picturesque tea plantations and rich tea heritage, is the birthplace of these exceptional teas. M2Bio Sciences has collaborated with esteemed tea experts in Kenya to bring the essence of this remarkable region to tea enthusiasts and health-conscious individuals worldwide.
Purple Tea, grown exclusively in the pristine highlands of Kenya, is distinguished by its stunning violet leaves. This unique variety is packed with anthocyanins, potent antioxidants known for their anti-inflammatory properties. Purple Tea offers remarkable health benefits, such as supporting cardiovascular health, boosting the immune system, and promoting healthy aging. Its distinct taste profile, a harmonious blend of fruity and earthy notes, elevates the tea-drinking experience to new heights. [1-2-3-4]
White Tea, carefully handpicked from tender tea leaves and buds, is prized for its delicate and nuanced flavors. With minimal processing, White Tea retains a higher concentration of antioxidants compared to other tea varieties. Regular consumption of this exquisite tea can aid in detoxification, promote healthy skin, and provide anti-aging benefits. The mild and soothing character of White Tea creates a truly calming and rejuvenating experience. [2-3-4-5]
Green Tea, beloved for its vibrant green hue and refreshing taste, has been celebrated for centuries for its multitude of health benefits, including the prevention of cancer, cardiovascular diseases and the anti-inflammatory. Bursting with polyphenols and catechins, Green Tea offers powerful antioxidants that support heart health, enhance cognitive function, and aid in weight management. Its invigorating flavor and energizing properties make it a perfect choice for those seeking a healthful boost throughout the day. [2-3-4-6-7-8]
“We are delighted to introduce our exceptional line of Purple, White, and Green teas from Kenya,” stated Jeff Robinson, CEO of M2Bio Sciences. “Our Purple tea strain has about 135 times more antioxidants [9] compared to a traditional black tea so we definitely tick the box for health. In terms of addressable market, according to a report published by Vantage Market Research, the Global Green Tea Market was valued at USD 13.41 Billion in 2021 and is projected to reach USD 26.16 Billion by 2028 with a CAGR of 8.71%.[10] We plan to take a good chunk of that!” Robinson added. “These teas embody our commitment to providing products that promote holistic well-being. Through our partnership with the esteemed tea experts of Kenya and our team of researchers in the M2Bio Phytomedicine Labs at the University of Pretoria, we are able to offer tea enthusiasts worldwide an unparalleled combination of extraordinary taste and outstanding health benefits.”
In a display of dedication to sustainable sourcing practices, CEO Jeff Robinson will embark on a journey to Kenya from July 24th to July 31st. During his visit, Mr. Robinson will engage with local tea farmers, explore initiatives promoting sustainability, and strengthen the partnership between M2Bio Sciences and the Kenyan tea community. This trip underscores the company’s commitment to ethical practices, supporting local economies, and ensuring the highest quality of its tea offerings.
The captivating Purple, White, and Green teas from Kenya will be available for purchase online and through select retailers starting in Q1 2024. M2Bio Sciences invites tea enthusiasts and health-conscious individuals to embark on a transformative tea-drinking experience, harnessing the exceptional flavors and medicinal benefits of these extraordinary teas.
References
[1] Joshi R, Rana A, Kumar V, Kumar D, Padwad YS, Yadav SK, Gulati A. Anthocyanins enriched purple tea exhibits antioxidant, immunostimulatory and anticancer activities. J Food Sci Technol. 2017 Jun;54(7):1953-1963. doi: 10.1007/s13197-017-2631-7. Epub 2017 Apr 18. PMID: 28720952; PMCID: PMC5495722. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495722/ [2] Cory H, Passarelli S, Szeto J, Tamez M, Mattei J. The Role of Polyphenols in Human Health and Food Systems: A Mini-Review. Front Nutr. 2018 Sep 21;5:87. doi: 10.3389/fnut.2018.00087. PMID: 30298133; PMCID: PMC6160559. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160559/ [3] Hollman PC, Feskens EJ, Katan MB. Tea flavonols in cardiovascular disease and cancer epidemiology. Proc Soc Exp Biol Med. 1999 Apr;220(4):198-202. doi: 10.1046/j.1525-1373.1999.d01-33.x. PMID: 10202388.https://pubmed.ncbi.nlm.nih.gov/10202388/ [4] Tang GY, Meng X, Gan RY, Zhao CN, Liu Q, Feng YB, Li S, Wei XL, Atanasov AG, Corke H, Li HB. Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review. Int J Mol Sci. 2019 Dec 8;20(24):6196. doi: 10.3390/ijms20246196. PMID: 31817990; PMCID: PMC6941079. https://pubmed.ncbi.nlm.nih.gov/31817990/ [5] Kouhihabibidehkordi G, Kheiri S, Karimi I, Taheri F, Bijad E, Bahadoram M, Alibabaie Z, Asgharian S, Zamani H, Rafieian-Kopaei M. Effect of White Tea (Camellia sinensis) Extract on Skin Wound Healing Process in Rats. World J Plast Surg. 2021 Jan;10(1):85-95. doi: 10.29252/wjps.10.1.85. PMID: 33833959; PMCID: PMC8016378.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016378/ [6] Tannis M Jurgen,s Anne Marie Whelan, Lara Killian, Steve Doucette, Sara Kirk, Elizabeth Foy, Authors’ declarations of interest Green tea for weight loss and weight maintenance in overweight or obese adults Version published: 12 December 2012 Version history https://doi.org/10.1002/14651858.CD008650.pub2 [7] M. Tolmie; Z. Apostolides; M. J. Bester; J. C. Serem; M. Nell The potential antidiabetic properties of green and purple tea [ Camellia sinensis (L.) O Kuntze], purple tea ellagitannins, and urolithins Citation DataJournal of Ethnopharmacology, ISSN: 0378-8741, Vol: 309, Page: 116377 Publication Year2023, DOI10.1016/j.jep.2023.116377 PMID36907477 http://www.sciencedirect.com/science/article/pii/S0378874123002453 [8] Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: a literature review. Chin Med. 2010 Apr 6;5:13. doi: 10.1186/1749-8546-5-13. PMID: 20370896; PMCID: PMC2855614.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855614/ [9] Khan et al., Med Aromat Plants (Los Angeles) Purple Tea Composition and Inhibitory Effect of Anthocyanin-Rich Extract
on Cancer Cell Proliferation 2018, 7:6 DOI: 10.4172/2167-0412.1000322 https://www.semanticscholar.org/paper/Purple-tea-composition-and-inhibitory-effect-of-on-Khan-Bashir/b214419bc08ee495790648719dd5d40026932fe2 [10] Vantage Market Research Green-Tea-Market-Size-Share-to-Surpass-26-16-Billion-by-2028-Vantage-Market-Research
About Institute of Biomedical Research Corp./ DBA M2Bio Sciences
Institute of Biomedical Research Corp, is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions, that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, Liviana™ brands as well as artificial intelligence powered nutrition products and solutions under the M2Biome brand. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies such as artificial intelligence. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol “MRES”.
Publicly traded Company (OTC Pink: MRES)
www.m2bio.co
[email protected]
+27 72 333 2148
Find M2Bio™ on social media
Facebook: M2Bio
Instagram: M2bio.Sciences
LinkedIn: M2Bio
Twitter: @M2bio
Forward-Looking Statements
Safe Harbour Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences to include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency, and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.
IBN
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]